Beijing Hotgen Biotech Co., Ltd.
Beijing Hotgen Biotech Co., Ltd. is a China-based supplier focused on in vitro diagnostic (IVD) raw materials and related products. The company emphasizes its breadth in producing recombinant antigens and antibodies, with a catalog that includes over 100 varieties of recombinant antigens and antibodies. The firm highlights its export experience, noting that its raw materials have been shipped to North America, and underscores a reputation for consistent quality, large batch production, and minimal batch-to-batch variation.
The company structures its offerings into three main product groups. First, McAbs (monoclonal antibodies) and recombinant protein products designed for enzyme-linked immunosorbent assay (ELISA) development and rapid test production. The McAbs in the catalog cover antibodies for a range of infectious diseases and tumor markers, including targets such as AFP, t-PSA, CA125, CEA, CA153, CA724, CRP, IgA, albumin Mab, and others. The firm notes high sensitivity for specific antibodies, citing an anti-HIV-p24 with detection capability down to 10 pg, which points to a focus on high-sensitivity reagents.
Second, recombinant products are listed, including HIV-Ag, TP-Ag, HCV-Ag, TB-Ag, HBV-Ag, HTLV-Ag, Protein A, and Protein L. These materials are described as suitable for use in enzyme immunoassays and rapid test strips, suggesting applicability across various diagnostic formats.
Third, the company provides diagnostic test kits and related reagents, with examples such as rapid tests for HCV, AFP, and influenza A/B, as well as ELISA reagents for targets including t-PSA, CEA, AFP, CYFRA21.1, flu antigens, HIV ELISA panels, HIV-1 p24 ELISA, HIV Ag/Ab ELISA, syphilis ELISA, and HTLV and TB ELISA tests. Additional items encompass accessories used in diagnostic test manufacturing, such as AFP-L3 rapid test device components, Protein A options, and various Sepharose-based materials.
Beijing Hotgen Biotech also highlights its capability to engage in original equipment manufacturing (OEM) for diagnostic tests, including ELISA and rapid tests, as well as chemiluminescence assays. The company positions itself as a supplier that can support both in-house production of diagnostic tests and private-label or co-developed solutions for clients seeking OEM partnerships.
The firm’s profile emphasizes a focus on quality, large-batch production, and stability across lots, aiming to support reliable performance in diagnostic applications. While specific regulatory certifications or laboratory standards are not detailed in the provided materials, the emphasis on high-quality raw materials and a track record of export to international markets suggests adherence to industry norms for IVD components.
Overall, Beijing Hotgen Biotech Co., Ltd. appears to serve as a comprehensive source for IVD raw materials and diagnostic components, with a portfolio that covers monoclonal antibodies, recombinant proteins, diagnostic reagents, and OEM manufacturing capabilities. The company’s offering aligns with suppliers that support the development and production of ELISA-based assays and rapid diagnostic tests, compatible with a range of disease targets and biomarker panels.
